These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2793383)

  • 21. Phase II trial of acivicin in malignant mesothelioma.
    Falkson G; Vorobiof DA; Simson IW; Borden EC
    Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Adelson MD; Hanjani P
    Invest New Drugs; 1990 Nov; 8(4):377-9. PubMed ID: 2084071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
    Hidalgo M; Rodriguez G; Kuhn JG; Brown T; Weiss G; MacGovren JP; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Nov; 4(11):2763-70. PubMed ID: 9829740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acivicin. An antitumor antibiotic.
    Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
    Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
    Weiss GR; McGovren JP; Schade D; Kufe DW
    Cancer Res; 1982 Sep; 42(9):3892-5. PubMed ID: 7105049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II study.
    Gebbia V; Di Marco P; Borsellino N; Gebbia N; Valerio MR; Fallica G; Tirrito ML; Valenza R; Citarrella P; Benedetti Panici P
    Anticancer Drugs; 2003 Jun; 14(5):359-64. PubMed ID: 12782942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.
    Alberts DS; Mason-Liddil N; Stock-Novack D; O'Toole RV; Abbott TM; Salmon SE
    Am J Clin Oncol; 1992 Apr; 15(2):146-9. PubMed ID: 1553903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.
    Surwit EA; Alberts DS; O'Toole RV; Graham V; Hannigan EV; Stephens RL; Boutselis JG
    Gynecol Oncol; 1987 Jun; 27(2):214-9. PubMed ID: 3570059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acivicin in 1985.
    Earhart RH; Neil GL
    Adv Enzyme Regul; 1985; 24():179-205. PubMed ID: 3915184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.
    Strauss HG; Hemsen A; Karbe I; Lautenschläger C; Persing M; Thomssen C
    Anticancer Drugs; 2008 Jun; 19(5):541-5. PubMed ID: 18418221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of acivicin in advanced metastatic breast cancer.
    Fleishman G; Yap HY; Murphy WK; Bodey G
    Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study.
    Bonomi P; Finkelstein D; Chang A
    Am J Clin Oncol; 1994 Jun; 17(3):215-7. PubMed ID: 8192104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
    Hartmann JT; Kanz L; Bokemeyer C
    Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusional vinorelbine in relapsed or refractory lymphomas.
    Sarris AH; Psyrri A; Hagemeister F; Romaguera J; McLaughlin P; Rodriguez MA; Bachier C; Younes A; Mesina O; Oholendt M; Medeiros LJ; Samuels B; Adams LM; Cabanillas F
    Leuk Lymphoma; 2000 Oct; 39(3-4):291-9. PubMed ID: 11342309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.
    Burger RA; DiSaia PJ; Roberts JA; O'rourke M; Gershenson DM; Homesley HD; Lichtman SM; Barnes W; Moore DH; Monk BJ
    Gynecol Oncol; 1999 Feb; 72(2):148-53. PubMed ID: 10021293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
    Muggia FM; Hainsworth JD; Jeffers S; Miller P; Groshen S; Tan M; Roman L; Uziely B; Muderspach L; Garcia A; Burnett A; Greco FA; Morrow CP; Paradiso LJ; Liang LJ
    J Clin Oncol; 1997 Mar; 15(3):987-93. PubMed ID: 9060537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
    Schwartsmann G; Mans DR; Menke CH; Xavier N; Caleffi M; Ferreira Filho AF; Schunemann H; Kalakun L; Koya R; Pohlman P; Venegas LF
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):24-9. PubMed ID: 9144687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
    McGuire WP; Blessing JA; Berman ML
    Invest New Drugs; 1989 Nov; 7(4):333-6. PubMed ID: 2557300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.